fluphenazine has been researched along with Tremor in 8 studies
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen di- and tripeptide analogues of MIF, Pro-Leu-Gly-NH2, have been synthesized and assayed for inhibition of oxotremorine-induced tremor." | 7.66 | Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor. ( Björkman, S; Castensson, S; Sievertsson, H, 1979) |
| "Fourteen di- and tripeptide analogues of MIF, Pro-Leu-Gly-NH2, have been synthesized and assayed for inhibition of oxotremorine-induced tremor." | 3.66 | Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor. ( Björkman, S; Castensson, S; Sievertsson, H, 1979) |
| ""Rubral" tremor is a rare movement disorder that occurs typically with midbrain damage." | 1.28 | "Rubral" tremor induced by a neuroleptic drug. ( Friedman, JH, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| YAMAUCHI, I | 1 |
| Björkman, S | 2 |
| Lewander, T | 1 |
| Zetterström, T | 1 |
| Schrader, G | 1 |
| Wong, C | 1 |
| Russell, R | 1 |
| Goldney, RD | 1 |
| Freed, ED | 1 |
| Strauss, AJ | 1 |
| Bailey, RK | 1 |
| Dralle, PW | 1 |
| Eschmann, AJ | 1 |
| Wagner, RB | 1 |
| Castensson, S | 1 |
| Sievertsson, H | 1 |
| Frangos, H | 1 |
| Zissis, NP | 1 |
| Leontopoulos, I | 1 |
| Diamantas, N | 1 |
| Tsitouridis, S | 1 |
| Gavriil, I | 1 |
| Tsolis, K | 1 |
| Friedman, JH | 1 |
1 trial available for fluphenazine and Tremor
| Article | Year |
|---|---|
Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluphenazine; Fluspir | 1978 |
7 other studies available for fluphenazine and Tremor
| Article | Year |
|---|---|
[Studies on the effects of fluphenazine upon minor tremor (MT) and EEG in schizophrenics by automatic frequency analyser].
Topics: Electroencephalography; Fluphenazine; Humans; Schizophrenia; Tremor | 1963 |
MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
Topics: Amphetamine; Animals; Catalepsy; Fluphenazine; Humans; Male; Mice; Motor Activity; MSH Release-Inhib | 1980 |
The neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Cognition Disorders; Consciousness Disorders; Fever; Fluphenazine; Humans; Mal | 1981 |
Rapid tremor of the eyelids after overdose of fluphenazine.
Topics: Adult; Blinking; Eyelid Diseases; Fluphenazine; Humans; Male; Tremor | 1983 |
Conventional psychotropic-induced tremor extinguished by olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Fluphenazine; Haloperidol; Humans; Male; Menta | 1998 |
Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
Topics: Animals; Catalepsy; Chemical Phenomena; Chemistry; Fluphenazine; Humans; Male; Mice; Molecular Confo | 1979 |
"Rubral" tremor induced by a neuroleptic drug.
Topics: Adult; Benztropine; Bromocriptine; Corpus Striatum; Fluphenazine; Humans; Male; Neural Pathways; Red | 1992 |